{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-119032","form_type":"8-K","ticker":"TBPH","cik":"0001583107","company_name":"Theravance Biopharma, Inc.","filed_at":"2025-12-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.824764+00:00","generated_at":"2026-05-16T13:58:11.089008+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"low","headline":"Theravance holds ampreloxetine KOL event; AGM set for June 12, 2026","bullets":["Virtual KOL investor event for ampreloxetine held Dec. 8, 2025; slide deck furnished as exhibit.","2026 Annual General Meeting scheduled for June 12, 2026 in Dublin, Ireland.","Proxy materials will be filed with SEC and made available to shareholders prior to the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-119032","json":"https://secwatch.observer/filing/0001104659-25-119032.json","markdown":"https://secwatch.observer/filing/0001104659-25-119032.md","text":"https://secwatch.observer/filing/0001104659-25-119032.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583107/000110465925119032/0001104659-25-119032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583107/000110465925119032/tm2532919d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:58:11.089008+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}